To explore the role of RNA modifications in regulating bacterial fitness, pathogenicity, and host innate immune responses during bacterial respiratory infections, particularly focusing on Pseudomonas aeruginosa and their implications for antimicrobial resistance.
Key Findings:
RNA modifications regulate both bacterial fitness and the host's immune response, impacting treatment outcomes.
Dysregulation of epitranscriptomic and epigenetic modifications can lead to exacerbated infectious diseases and complicate therapeutic strategies.
Innate immune memory involves crosstalk between epigenetic and epitranscriptomic regulation, influencing long-term immune responses.
Interpretation:
A detailed understanding of RNA modifications can help identify new therapeutic targets for managing bacterial respiratory infections and addressing the growing challenge of antimicrobial resistance.
Limitations:
The review primarily focuses on Pseudomonas aeruginosa and may not generalize to other pathogens, limiting broader applicability.
Exclusion of studies on optimized antimicrobial agents limits the scope of findings and potential solutions.
Conclusion:
Understanding the RNA modification landscape is crucial for developing new strategies against bacterial respiratory infections and urgently addressing the challenge of antimicrobial resistance.
